Drawing for LOMILIN

USPTO serial 78862547

LOMILIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FRENCH, CURTIS W
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LOMILIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Linda M. Byrne, Robert Crawford, Eric Curtin

Linda M. Byrne Crawford Maunu PLLC1150 Northland Drive, Suite 100St. Paul, MN 55120UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for topical, intra-vaginal and/or intra-anal application, namely, pharmaceutical preparations for use in treating the skin diseases of warts, verruca vulgaris, verruca plantaris, verruca plana, flat condylomata, mosaic-type warts, butcher's warts, anogenital warts, condylomata accuminata, hyperplasia of the epidermis, recalcitrant cutaneous warts, herpes infection, genital and anal herpes infection, shingles, Molluscum contagiosum, mycosis, mycosis fungoides, tinea, tinea pedis, pigmentation disorders, hyperpigmentation, hypopigmentation, vitiligo, melasma, atypical/displastic/melanocytic nevi, sun-damaged skin, removal of tattoos, psoriasis, neurodermitis, dermatitis, atopic dermatitis, cutaneous atopy, eczema, lichen planus, cutaneous lupus erythematosus, skin ulcers, rosacea, precancerous and cancerous lesions, increased proliferation of skin cells, actinic keratosis, actinic cheilitis, keloids, lentigo, hemangioma, Epidermodysplasia verruciformis, Bowen's disease, Bowenoid papulosis, basal cell carcinoma, intraepithelial squamous cell carcinoma, melanoma, and other skin cancers, neoplasias, cervical dysplasia, cervical intraepithelial neoplasias, anal intraepithelial neoplasias, vulvar intraepithelial neoplasia, penile cancer, vulvovaginal cancer, anal carcinoma, cervical carcinoma, cutaneous T-cell lymphoma, alopecia, vulvodynia, keloid and hypertrophic scars, post surgical excision on scar cosmesis, hyperkeratosis, seborrhea, Darier's disease, porokeratosis of mibelli, ichthyosis, xerosis, dartroud disthesis, acne, nasal papilloma, oral papilloma, focal epithelial hyperplasia, laryngeal papilloma, recurrent respiratory papillomatosis and conjunctival papillomaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 22, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 22, 2008ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 3, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 4, 2008EX2GSOU EXTENSION 2 GRANTED—
Jan 15, 2008EXT2SOU EXTENSION 2 FILED—
Jan 15, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2007DOCKASSIGNED TO EXAMINER—
May 21, 2007EX1GSOU EXTENSION 1 GRANTED—
May 21, 2007EXT1SOU EXTENSION 1 FILED—
May 21, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 20, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 28, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2006NPUBNOTICE OF PUBLICATION—
Oct 6, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 5, 2006ALIEASSIGNED TO LIE—
Sep 29, 2006ALIEASSIGNED TO LIE—
Sep 22, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2006DOCKASSIGNED TO EXAMINER—
Apr 21, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance